Back
Intra-Cellular Therapies Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Sell
26
ITCI
Intra-Cellular Therapies
Last Price:
77.64
Seasonality Move:
-4.41%
Sell
28
ACAD
ACADIA Pharmaceuticals
Last Price:
16.53
Seasonality Move:
0.51%
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $76.97. The Score for ITCI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $16.53. The Score for ACAD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $76.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $16.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 61.02 | Buy |
Chaikin Money Flow: | 455173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 54.11 | Buy |
Chaikin Money Flow: | 1056502 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.71 - 16.39) | Buy |
Bollinger Bands (100): | (15.03 - 17.49) | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.11 | Buy |
20-day SMA: | 74.12 | Buy |
50-day SMA: | 75.78 | Buy |
200-day SMA: | 70.5 | Buy |
8-day EMA: | 75.2 | Buy |
20-day EMA: | 74.76 | Buy |
50-day EMA: | 74.42 | Buy |
200-day EMA: | 69.87 | Buy |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.24 | Buy |
20-day SMA: | 16.15 | Buy |
50-day SMA: | 16.84 | Sell |
200-day SMA: | 19.95 | Sell |
8-day EMA: | 16.29 | Buy |
20-day EMA: | 16.23 | Buy |
50-day EMA: | 16.42 | Buy |
200-day EMA: | 18.67 | Sell |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.88 per share, and an increase next year of $0.31 per share.
Intra-Cellular Therapies Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ACADIA Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |